Recombinant IL23A (Risankizumab Biosimilar) antibody

Catalog No. ABIN7795149

The Human Monoclonal anti-IL23A (Risankizumab Biosimilar) antibody is suitable to detect IL23A (Risankizumab Biosimilar) in samples from Human. It has been validated for FACS and in vivo.

Quick Overview for Recombinant IL23A (Risankizumab Biosimilar) antibody (ABIN7795149)

Target: IL23A (Risankizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This IL23A (Risankizumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Grade: Research Grade

Product Details anti-IL23A (Risankizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Risankizumab Biosimilar, Human IL-23A (p19) Monoclonal Antibody

Characteristics: The anti-human IL-23A (p19) monoclonal antibody risankizumab biosimilar was produced in mammalian cells.

Purification: Protein A or G affinity column

Purity: >95 % by reducing SDS-PAGE

Endotoxin Level: < 1 EU per 1 mg of the protein by the LAL method

Isotype: IgG1, kappa

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: > 3 mg/mL

Storage: 4 °C,-20 °C

Storage Comment: Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.

Target Details for IL23A (Risankizumab Biosimilar)

Target: IL23A (Risankizumab Biosimilar)

Alternative Name: Risankizumab Biosimilar

Target Type: Biosimilar